Mono or Dual Antiplatelet Therapy for Treating Patients with Peripheral Artery Disease after Lower Extremity Revascularization: A Systematic Review and Meta-Analysis
The efficacy of dual antiplatelet therapy (DAPT) for patients with peripheral artery disease (PAD) after lower-limb intervention remains controversial. Currently, the prescription of DAPT after an intervention is not fully recommended in guidelines due to limited evidence. This study compares and an...
Saved in:
Main Authors: | Shang-Yu Tsai (Author), Ying-Sheng Li (Author), Che-Hsiung Lee (Author), Shion-Wei Cha (Author), Yao-Chang Wang (Author), Ta-Wei Su (Author), Sheng-Yueh Yu (Author), Chi-Hsiao Yeh (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of rivaroxaban-based dual antithrombotic and antiplatelet therapies for symptomatic patients with lower-extremity peripheral artery disease post-revascularization: a retrospective cohort study
by: Ye Ji, et al.
Published: (2023) -
Short vs prolonged dual antiplatelet treatment upon endovascular stenting of peripheral arteries
by: Kronlage M, et al.
Published: (2017) -
DURATION OF DUAL ANTIPLATELET THERAPY
by: O. L. Barbarash
Published: (2016) -
In silico Investigation on Clopidogrel, Prasugrel and Ticagrelor as Potential Mono Antiplatelet Therapy for Acute Coronary Syndrome
by: Muhammad Naufal Hibatullah, et al.
Published: (2024) -
DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE
by: G. N. Guseva, et al.
Published: (2015)